Analysis Elixxer Ltd. (ELIXF)
5/26/2024
Analysis of Elixxer Ltd. (ELIXF)
Elixxer Ltd. (ELIXF) has been showing a consistent price close of 0.00610 over the past few days. The Relative Strength Index (RSI) indicator is at 0.00000, indicating a neutral position. The Moving Average Convergence Divergence (MACD) indicator is showing a negative value, with the MACD line below the signal line.In terms of moving averages, the Simple Moving Average (SMA) is at 0.01026, the Exponential Moving Average (EMA) is at 0.00992, and the Weighted Moving Average (WMA) is at 0.00878. This suggests a downward trend in the stock price.
Overall, based on the indicators and moving averages, Elixxer Ltd. seems to be in a neutral to bearish position. Traders and investors may want to closely monitor the stock for any potential changes in trend.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The results for the quarter ending on January 31, 2025, were released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.33.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.44.
Moving on to stock statistics, the company has a short ratio of 1.66, with 94.31 million shares shorted out of 15.31 billion float shares. The average 10-day trading volume is 52.90 million shares, while the average 90-day trading volume is 62.82 million shares. The stock has a market capitalization of $2.91 trillion.
Valuation metrics show a PEG ratio of 26.21, forward P/E of 26.21, and trailing P/E of 29.43. The enterprise value is $2.95 trillion, with a price-to-book ratio of 39.18 and price-to-sales ratio of 7.62. The stock has an enterprise-to-EBITDA ratio of 22.75 and an enterprise-to-revenue ratio of 7.73.
The stock price summary includes a beta of 1.264, a 50-day moving average of $173.69, a 200-day moving average of $180.79, a 52-week low of $164.08, and a 52-week high of $199.62.
Lastly, dividends and splits information indicate a payout ratio of 14.93%, with a forward annual dividend rate of $1 and a trailing annual dividend rate of $0.97. The company's dividend yield is 0.53% and the last split date was on August 31, 2020, with a 4-for-1 split. The ex-dividend date is May 10, 2024, and the dividend date is May 16, 2024.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, indicating efficient cost control measures.
4. The operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. The net income has also been increasing, with a significant rise from $57.4 billion in 2020 to $97 billion in 2023.
6. Earnings per share (EPS) have shown a positive trend, reflecting the company's profitability and potential for growth.
7. The company has been able to maintain a consistent number of outstanding shares, which is important for investors' equity stake.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and shows a growth trajectory.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has shown an increasing trend, with the highest value in 2018 at $107,147,000,000.
6. The company has been investing more in non-current assets over the years, indicating potential long-term growth strategies.
7. The company has been relying more on long-term debt to finance its operations, as seen in the increasing trend of non-current liabilities.
8. The company has been effectively managing its retained earnings, as reflected in the increasing shareholders' equity.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on generating positive cash flows from operating activities.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, compared to $1.26 a year ago. The range of estimates is between $1.27 and $1.36, based on 26 analysts' forecasts.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, lower than the $1.46 EPS reported a year ago. The EPS estimates range from $1.44 to $1.63, with input from 25 analysts.
3. Looking at the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, up from $6.13 in the previous year. The EPS estimates for the year range from $6.43 to $6.92, based on forecasts from 39 analysts.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, slightly higher than the $6.59 EPS reported for the previous year. The EPS estimates for the upcoming year range from $6.40 to $7.90, with input from 39 analysts.
Overall, the analysts are generally forecasting an increase in earnings per share for both the current and next fiscal years, with some fluctuations expected in the quarterly results.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates indicate a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the historical average. However, the company is still projected to experience solid growth both in the short and long term according to analyst consensus.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.MACD of ELIXF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
